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OBJECTIVES: Obesity is an important risk factor for the development of colorectal cancer (CRC). Although the impact of bariatric
surgery on CRC is conflicting, its impact on precursor lesions is unknown. The aim of this study was to determine whether bariatric
surgery before index screening colonoscopy is associated with decreased development of colorectal adenomas.
METHODS: We performed a retrospective cohort study of bariatric surgery patients who had undergone index, screening
colonoscopy at an academic center from 2001 to 2014. Patients who had bariatric surgery at least 1 year before index colonoscopy
were compared with those who had surgery after colonoscopy, using multivariable logistic regression to control for presurgical
body mass index, sex, gender, race, type of surgery, aspirin use, metformin use, smoking, and age at colonoscopy.
RESULTS: One hundred and twenty-five obese individuals who had bariatric surgery before colonoscopy were compared with 223
individuals who had colonoscopy after surgery. Adenomatous polyps were found in 16.8% of individuals who had surgery first vs.
35.5% who had colonoscopy before bariatric surgery (unadjusted odds ratio (OR) 0.37, 95% confidence interval (CI): 0.21–0.64,
P= 0.0003). After multivariable adjustment, bariatric surgery before index screening colonoscopy was associated with a decreased
risk of adenomas at index colonoscopy (adjusted OR 0.37, 95% CI: 0.19–0.69, P= 0.002).
CONCLUSIONS: Bariatric surgery is associated with a decreased risk of colorectal adenomas in obese individuals without a family
history of CRC.
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INTRODUCTION
Both obesity and cancer, debilitating diseases, carry an
increasingly heavy burden on patients and the health-care
system.1 A significant fraction of colorectal cancer is attribu-
table to modifiable risk factors such as obesity.2,3 The link
between increased body mass index (BMI) and cancer is
under an area of heavy investigation, and several publications
have addressed the epidemiological link.4,5 Mechanisms for
the causal link have also been proposed, with the American
Society of Clinical Oncology advocating the development of
strategies to reduce the impact of obesity on cancer.4,6,7 In
relation to colorectal adenomas specifically, previouswork has
shown an increased risk of colorectal adenomas in both
men and women who are obese compared with non-obese.8
Although it is widely accepted that colorectal cancer
develops as a consequence of accumulation of genetic
alterations during which normal epithelium is transformed into
adenomas, which eventually progress to cancer, the exact
mechanism of obesity on these steps is yet to be fully
characterized.9
Patients who undergo bariatric surgery have the potential to
achieve significant weight loss, accompanied by a significant
reduction in mortality rates for those with severe obesity.10
Currently, there is controversy as to whether bariatric surgery
increases or decreases the risk of colorectal cancer.11,12
Furthermore, guidelines for screening of individuals with
obesity for colorectal cancer are undeveloped.13 The assump-
tion that bariatric surgeries reduce CRC risk has been recently
tested. In a large cohort study of colorectal cancer incidence
after bariatric surgery, standardized incidence ratio for CRC
following bariatric surgery increased with time (95% con-
fidence interval [CI]: 1.48–2.64) 10 years after surgery.11 Other
studies have refuted this claim, showing a reduction in cancer-
related mortality in bariatric patients.12,14,15 Given the fact that
adenomas are precursor lesions of colorectal cancer, we
sought to investigate whether bariatric surgery is associated
with change in the proportion of individuals who harbor
colorectal adenomas. To that end, we conducted a retro-
spective chart review of bariatric surgery patients without a
family history of CRC, who had index screening colonoscopies
at our institution.
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METHODS
Study population. Records from Massachusetts General
Hospital (MGH) were reviewed to identify patients who had
bariatric surgery at the institution between the years 2000
and 2014 using the Research Patient Data Registry, a
Partners Healthcare query database.16 The study was
approved by MGH Institutional Review Board (protocol
number 2015P002548). All data were collected by detailed
review of electronic medical records to identify patients who
had bariatric surgery performed after evaluation by the MGH
Weight Center. Cases were defined as patients without a
family history of CRC who had bariatric surgery before their
index screening colonoscopy, which were performed at an
MGH or its affiliates, with full records available for analysis.
Controls were defined as patients who underwent their
bariatric surgery after their index screening colonoscopy.
Bariatric surgery was defined as open or laproscopic Roux-
en-Y gastric bypass (RYGB), gastric sleeve, and banding
aimed at invoking weight loss and its accompanying
metabolic changes.
All patients enrolled in the study were required to have had
their index screening colonoscopy performed by gastroenter-
ologists at MGH or a Partners Healthcare-affiliated institution
with colonoscopy and pathology reports available for review.
Patients with known family history of adenomas or colon
cancer were excluded, as well as those with incomplete
exams, poor prep, or indications other than screening. In
addition, to account for undocumented indications other than
screening, we selected individuals who underwent index
colonoscopy at age 49–60 years. Patients who had a
colonoscopy less than a year after bariatric surgery also were
excluded given that the maximal weight loss may not have
been fully achieved. Three hundred and twenty-eight patients
were eligible for analysis.
Covariates. Based on the pre-existing literature, the follow-
ing variables were included in regression models as potential
confounders in the association between bariatric surgery
before index screening colonoscopy and adenoma develop-
ment: age at the time of index screening colonoscopy, sex,
race (white vs. non-white), presurgical BMI, type of bariatric
surgery, smoking status, metformin use, and aspirin use.
Exploratory analyses were conducted where we corrected for
BMI at the time of colonoscopy, as well as any interaction
between BMI at the time of colonoscopy and bariatric surgery
before colonoscopy.
Statistical analysis. For univariate analyses, means and
standard deviations were calculated for continuous variables,
and analyzed using unpaired Student's t-tests. Categorical
variables were analyzed with either χ2 or two-tailed Fisher’s
exact tests. Po0.05 were considered significant.
To correct for potential confounders in the association of
tubular adenoma development with bariatric surgery before
colonoscopy, we performed a binomial logistic regression
additionally incorporating age at index screening colonos-
copy, sex, race, presurgical BMI, bariatric surgery type, any
aspirin use within 10 years, smoking status, and any
metformin use. Regression coefficients with Po0.05 were
considered significant. R 3.1.0 × 64 was used to perform all
statistical tests.
Table 1 Demographic characteristics of bariatric surgery cohort
Cohort (n= 328) Bariatric surgery before colonoscopy—
125 (38.1%)
Bariatric surgery after colonoscopy—203
(61.9%)
P value
Age at surgery 47.3±0.3 56.5±0.3 o0.0001
Age at colonoscopy 52.4±0.2 53.7±0.20 o0.0001
Female sex—no. (%) 92 (73.60%) 45 (56.25%) 0.0963
BMI before surgery (kg/m2) 48.6±0.7 44.5±0.5 o0.0001
BMI 1 year after surgery( kg/m2) 30.9±1.0 33.1±0.6 0.0904
Time from surgery to colonoscopy (years) 5.0± 3.1 N/A
Type of surgery 0.9999
Lap Roux-en-Y 79 (63.20%) 143 (70.40%)
Lap sleeve 6 (4.80%) 43 (21.20%)
Lap gastric banding 5 (4.00%) 4 (2.00%)
Open Roux-en-Y 35 (28.00%) 13 (6.40%)
BMI at Colo (kg/m2) 31.55±1.24 42.74±0.89 o0.0001
Race—no. (%) 0.5348
White 102 (81.60%) 171(84.24%)
Black 9 (7.20%) 18(14.40%)
Hispanic 12 (9.60%) 13(10.40%)
Native American 1 (0.80%) 1(0.08%)
Asian 1 (0.80%) 0(0%)
Smokers—no. (%) 23 (18.40%) 34(16.75%) 0.7015
Metformin use—no.(%) 40 (32.00%) 50(24.63%) 0.1463
Aspirin use—no.(%) 40 (32.00%) 83(40.89%) 0.1064
Adenoma—no.(%) 21 (16.80%) 72(35.47%) 0.0003
BMI, body mass index; NA, not available.
Data are presented as themean plus/minus s.e. or number.P valueswere calculated byStudent’s t-test, two-tailed Fisher’s exact test, or χ2 test.P values less than 0.05
are in bold.
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RESULTS
Among the 328 eligible study participants, 125 individuals
underwent bariatric surgery before their index screening
colonoscopy (Table 1). Concordantly, the mean age at the
time of bariatric surgery between both groups was statistically
significant (47.3 vs. 56.5 years, Po0.0001), as well as BMI at
index colonoscopy (31.6 vs. 42.7 kg/m2,Po0.0001). Although
age at index colonoscopy of individuals who had bariatric
surgery before colonoscopy appeared significantly younger
(52.4 vs. 53.7 years, Po0.0001), the magnitude of the
difference appeared small. Both groups appeared to be
predominantly female and were non-smokers.
Regarding obesity-related metrics, study participants
demonstrated a reduction in BMI 1 year following their bariatric
procedure from their preoperative BMI. The mean preopera-
tive BMI was higher for those who underwent bariatric surgery
before colonoscopy compared with those who underwent
surgery after colonoscopy (48.6 vs. 44.5 kg/m2, Po0.0001,
and following the surgery, BMI decreased in both groups to
similar levels (30.9 vs. 33.1 kg/m2, P=0.09). Laparoscopic
RYGB was the most common procedure performed in both
groups.
Univariate analysis of adenoma risk demonstrated a
statistically significant fewer number of individuals with polyps
in those who had bariatric surgery before index colonoscopy
(16.8% vs. 35.5%, P=0.0003). To account for any potential
confounding factors, we performed a multivariable logistic
regression analysis of our data set with the outcome defined
as the presence or absence of adenomatous polyps (Table 2).
We also included well-established risk factors for the devel-
opment of adenomas including sex, race, smoking, aspirin
use, metformin use, and age at colonoscopy. In addition, we
included obesity-relatedmetrics including presurgical BMI and
type of bariatric surgery. From this analysis, we observed
bariatric surgery before index screening colonoscopy was still
significantly associated with decreased in the proportions with
adenomas (adjusted odds ratio (OR) 0.37, 95% confidence
interval (CI): 0.19–0.69, P=0.002). In addition, age at index
colonoscopy (adjusted OR 1.10, 95% CI: 1.00–1.21, P= 0.03)
and use of open RYGB (adjusted OR 2.71, 95%CI: 1.23–5.98,
P= 0.01) were significant factors.
As an exploratory analysis, we explored whether the effect
of bariatric surgery on the risk of adenoma development was
solely attributable to changes in BMI (Table 3). After
incorporating BMI at the time of colonoscopy into logistic
regressionmodels, we observed that the effect size of bariatric
surgery before colonoscopy was preserved. In addition, we
tested a model where a possible interaction exists between
bariatric surgery timing and BMI at the time of colonoscopy.
Both bariatric surgery and the interaction term became
significant.
DISCUSSION
The epidemic proportions of obesity in the United States, and
its increasing rates around the world, have aroused consider-
able concern about a downstream impact on cancer incidence
and mortality.1 Obesity is a modifiable risk factor, which makes
it an attractive target for reducing the burden of colorectal
cancer. Several studies have linked adult weight change with
the risk of colorectal cancer.17,18 The hypothesis that a
reduction in obesity may result in a subsequent decrease in
colon cancer incidence is rooted in the biological effects of
obesity on insulin resistance, adipokine levels, and gut
microbiota—all of which have been independently implicated
in cancer incidence and progression.19–22
Although the successful effects of bariatric surgery in
reducing known obesity-related comorbidities such as insulin
resistance, hypertension, and cardiovascular disease are well
established, its impact on colorectal cancer-related outcomes
thus far have beenmixed. Most notably, a large Swedish study
of over 15,000 bariatric patients demonstrated an increase in
the incidence of CRC.11,23,24 Other studies, including a
retrospective cohort mortality study and a recent meta-
analysis, have shown that bariatric surgery appears to
decrease CRC risk.12,15 Given these conflicting findings, we
sought to explore whether bariatric surgery is associated with
a reduction in the proportion of individuals with colorectal
adenomas found during index screening colonoscopy. By
selecting patients from the same weight loss center who had
Table 2 Factors affecting likelihood of adenomatous polyps at index screening colonoscopy using multivariable logistic regression analysis (n=328)
Parameter P value Odds ratio 95% CI for odds ratio
Intercept 0.0341
Bariatric surgery after index screening colonoscopy 1 (reference)
Bariatric surgery before index screening colonoscopy 0.0024 0.37 0.19, 0.69
Aspirin use 0.6514 1.13 0.66, 1.94
Metformin use 0.4018 1.30 0.70, 2.40
Sex (male) 0.6240 1.15 0.65, 2.05
Race (non-white) 1 (reference)
Race (white) 0.2189 1.61 0.77, 3.57
Procedure (laparoscopic RYGB) 1 (reference)
Procedure (laparoscopic gastric sleeve) 0.4161 1.34 0.65, 2.67
Procedure (laparoscopic gastric banding) 0.9583 1.05 0.14, 5.08
Procedure (open RYGB) 0.0131 2.71 1.23, 5.98
Smoking 0.1653 1.52 0.84, 2.73
Presurgical BMI 0.1842 0.97 0.94, 1.01
Age at colonoscopy 0.0349 1.10 1.01, 1.21
BMI, body mass index; CI, confidence interval; RYGB, Roux-en-Y gastric bypass.
P value less than 0.05 is in bold.
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bariatric surgery either before or after index screening
colonoscopy, we attempted to minimize unaccounted con-
founders, as all study participants were medically fit to
undergo bariatric surgery.
In a model for the development of adenomatous polyps,
bariatric surgery before index screening colonoscopy was
significantly associated with decreased risk of colorectal
adenomas. This association is particularly notable given the
higher presurgical BMI observed in those who received
surgery before colonoscopy. Reasons that previously well-
established risk factors such as sex and smoking were not
statistically significant include sample size, the large fraction of
women in the cohort, as well as the unknown impact of
traditional risk factors in the context of severe obesity.
Moreover, we could not ascertain exact duration and dosages
for medications such as aspirin and metformin because of
limitations in the electronic health record. The relatively higher
risk seen in open RYGB compared with other bariatric
surgeries may reflect other unaccounted, accompanying
comorbidities, given the strong preference for laparoscopic
approaches by surgeons and patients.
Exploratory analyses suggest that some of the protective
effects of bypass may be more than a simple consequence of
weight loss, particularly given that the magnitude of the effect
was preserved in logistic regression models after adjusting for
BMI at colonoscopy. Observational and basic science studies
support weight-independent effects of bariatric surgery.
Physiologically, insulin resistance is markedly reduced in
RYGB and gastric sleeve procedures in the immediate
postoperative period.25,26 Insulin resistance has been linked
to an increased rate of advanced adenomas27 through
activation of the insulin–insulin-like growth factor signaling
axis—which can upregulate Wnt signaling, expression of
antiapoptotic proteins, and Akt protein activation.28 Adiponec-
tin, a systemic adipokine, is increased after RYGB.29 In vitro,
adiponectin has been demonstrated to inhibit colon cancer cell
line proliferation through the regulation of signal transducer
and activator of transcription 3 signaling.30 Reproducible shifts
in the microbiome have been observed in RYGB patients can
alter host metabolism, and evident through microbiome
transfer experiments to germ-free mice.31 Mechanistic studies
to examine the effects of these microbial shifts on cancer
prevention are underway. Future studies with larger cohorts
will be required to elucidate the effect of these weight-
independent factors.
The key strength of our work is that unlike previous
epidemiological studies that examined whether bariatric
surgery affects CRC risk, we focused on precursor lesions
with extensive patient level data derived from an electronic
medical record. Our study is limited to a single-academic
center, as well as a population that is primarily Caucasian and
female. Given differences in body fat deposition and risks for
Table 3 Exploratory analyses incorporating BMI at the time of colonoscopy (n=328)
Parameter P value Odds ratio 95% CI for odds ratio
Model 1
Intercept 0.0142
Bariatric surgery after index screening colonoscopy 1 (reference)
Bariatric surgery before index screening colonoscopy 0.0028 0.33 0.16, 0.67
Aspirin use 0.6438 1.14 0.66, 1.94
Metformin use 0.4077 1.29 0.70, 2.38
Sex (male) 0.6946 1.12 0.63, 1.98
Race (non-white) 1 (reference)
Race (white) 0.2001 1.63 0.79, 3.60
Procedure (laparoscopic RYGB) 1 (reference)
Procedure (laparoscopic gastric sleeve) 0.4382 1.32 0.65, 2.67
Procedure (laparoscopic gastric banding) 0.8784 1.14 0.16, 5.49
Procedure (open RYGB) 0.0267 2.40 1.10, 5.24
Smoking 0.1470 1.55 0.85, 2.78
BMI at colonoscopy 0.9223 1.00 0.96, 1.03
Age at colonoscopy 0.0417 1.10 1.00, 1.20
Model 2
Intercept 0.0669
Bariatric surgery after index screening colonoscopy 1 (reference)
Bariatric surgery before index screening colonoscopy 0.0053 0.02 0.009, 0.28
Aspirin use 0.6530 1.13 0.66, 1.94
Metformin use 0.4155 1.29 0.69, 2.37
Sex (male) 0.5838 1.17 0.66, 2.09
Race (non-white) 1 (reference)
Race (white) 0.2187 1.61 0.77, 3.55
Procedure (laparoscopic RYGB) 1 (reference)
Procedure (laparoscopic gastric sleeve) 0.5686 1.23 0.60, 2.46
Procedure (laparoscopic gastric banding) 0.9920 0.99 0.14, 4.84
Procedure (open RYGB) 0.0364 2.31 1.05, 5.07
Smoking 0.0953 1.67 0.91, 3.03
BMI at colonoscopy 0.1840 0.97 0.93, 1.01
Age at colonoscopy 0.0525 1.09 1.00, 1.20
Bariatric surgery before colonoscopy ×BMI at colonoscopy (interaction) 0.0326 1.08 1.01, 1.16
BMI, body mass index; CI, confidence interval; RYGB, Roux-en-Y gastric bypass.
P values less than 0.05 are in bold.
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metabolic disorders among races, validation of these findings
in larger and more diverse cohorts will also be required.
In conclusion, we have demonstrated that bariatric surgery
before index screening colonoscopy is associated with a
decreased risk of adenomas in individuals without family
history of CRC. Our work further strengthens the hypothesis
that obesity is contributing to the appearance of precancerous
colorectal lesions, and offers the suggestion that the benefits
of bariatric surgery may extend to primary cancer prevention.
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WHAT IS CURRENT KNOWLEDGE
✓ Bariatric surgery results in weight reduction and
improvements in endocrine and cardiovascular risk factors.
✓ The impact of bariatric surgery on risk of colorectal
adenomas has not been studied.
WHAT IS NEW HERE
✓ Bariatric surgery before an index screening colonoscopy is
associated with a decreased incidence of colorectal
adenomas in those without family histories.
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